Course Summary
Contact Hour(s):
2 Contact Hours including 2 Advanced Pharmacology Hours
Author:
Katrina Pfeiffer, RN, MSN, CPN
This peer-reviewed course is applicable for the following professions:
Advanced Practice Registered Nurse (APRN), Certified Registered Nurse Anesthetist (CRNA), Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Registered Nurse (RN), Respiratory Therapist (RT)
Accreditations:
The American Nurses Credentialing Center (ANCC)
State Approvals:
Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353
Course Description:
This course discusses respiratory illnesses as a major cause of sickness and healthcare utilization in children. In the vulnerable pediatric population, these illnesses can rapidly progress from mild to life-threatening. Healthcare providers must have the knowledge and skills to accurately assess and differentiate between various respiratory conditions to provide timely intervention and treatment. It is vital clinicians provide patients and caregivers with comprehensive and clear education regarding the treatment and prevention of respiratory illness.
Outcomes:
≥ 92% of participants will be able to identify common pediatric respiratory illnesses.
Objectives:
After completing this continuing education course, the participant will be able to:
- Describe pediatric respiratory anatomy, physiology, and pathophysiology of pediatric respiratory illnesses.
- Differentiate between the signs and symptoms of common pediatric respiratory illnesses.
- Identify methods of definitive diagnosis for common pediatric respiratory illnesses.
- Describe clinical care and interventions for pediatric respiratory illnesses.
- Explain infection prevention methods for common pediatric respiratory illnesses.
Disclosures:
CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.